Which has the lower trailing P/E, AZN or DHR?

AZN has the lower trailing P/E: AZN trades at 24.30 and DHR at 37.17. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, AZN or DHR?

Over the past five years, AZN grew revenue faster — AZN at a 15.76% CAGR versus DHR at 1.97%.

Does AZN or DHR pay a bigger dividend?

AZN yields 2.02% and DHR yields 0.72% based on trailing dividends and the latest price.

Is AZN or DHR more profitable?

AZN runs the higher net margin — AZN at 17.02% versus DHR at 15.95%.

How have AZN and DHR total returns compared?

Over the past 10 years, AZN delivered 12.88% and DHR delivered 11.92% annualized total return. Past performance doesn't predict future results.

AstraZeneca PLC (AZN) vs Danaher Corporation (DHR)

A side-by-side comparison of AstraZeneca PLC and Danaher Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

AZN

AstraZeneca PLC

$251.01B

$161.85HealthcareDelayed quote: Sep 15, 2026, 4:00 PM EDT

DHR

Danaher Corporation

$147.13B

$209.29HealthcareDelayed quote: Sep 15, 2026, 4:00 PM EDT

Total return — AZN vs DHR

growth of $100 · dividends reinvested · last 10y

AZN +218.1% (+12.3%/yr)DHR +200.7% (+11.6%/yr)AZN compounded faster over this window

AZN DHR

AZN vs DHR: by the numbers

•AZN is the larger company ($251.01B vs $147.13B market cap).
•AZN trades at the lower trailing earnings multiple (24.30 vs 37.17 P/E), one valuation lens rather than an overall verdict.
•AZN converts more revenue to profit (17.02% vs 15.95% net margin).
•AZN grew revenue faster over the past five years (15.76% vs 1.97% CAGR).
•AZN pays the higher dividend yield (2.02% vs 0.72%).

Metrics side by side

Valuation

Metric	AZN	DHR
P/E ratio	24.30	37.17
Forward P/E	15.80	24.61
P/S ratio	4.09	5.86
P/B ratio	5.00	2.80
EV / EBITDA	13.69	23.44
FCF yield	3.48%	3.72%

Profitability

Metric	AZN	DHR
Gross margin	81.88%	58.51%
Operating margin	22.77%	20.42%
Net margin	17.02%	15.95%
ROE	20.79%	7.61%
ROIC	12.83%	5.03%

Dividends

Metric	AZN	DHR
Dividend yield	2.02%	0.72%
Payout ratio	48.50%	25.58%

Growth (annualized)

Metric	AZN	DHR
Revenue CAGR (5Y)	15.76%	1.97%
EPS CAGR (5Y)	22.02%	0.40%
FCF CAGR (5Y)	14.53%	-2.83%
Total return CAGR (5Y)	9.52%	-6.85%

Frequently asked

Which has the lower trailing P/E, AZN or DHR?: AZN has the lower trailing P/E: AZN trades at 24.30 and DHR at 37.17. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, AZN or DHR?: Over the past five years, AZN grew revenue faster — AZN at a 15.76% CAGR versus DHR at 1.97%.
Does AZN or DHR pay a bigger dividend?: AZN yields 2.02% and DHR yields 0.72% based on trailing dividends and the latest price.
Is AZN or DHR more profitable?: AZN runs the higher net margin — AZN at 17.02% versus DHR at 15.95%.
How have AZN and DHR total returns compared?: Over the past 10 years, AZN delivered 12.88% and DHR delivered 11.92% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AZN analysis Full DHR analysis Interactive comparison tool

Dig into the metrics

AstraZeneca P/E ratio Danaher P/E ratio AstraZeneca dividend yield Danaher dividend yield AstraZeneca ROE Danaher ROE AstraZeneca operating margin Danaher operating margin AstraZeneca revenue growth Danaher revenue growth AstraZeneca free cash flow Danaher free cash flow

AstraZeneca & Danaher appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Largest Companies by Market Cap

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.